NVIDIA
NVDA
Tesla
TSLA
Super Micro Computer
SMCI
4
Palantir
PLTR
5
Applovin
APP
US Stock MarketDetailed Quotes
IMNM Immunome
- 9.580
- -0.090-0.93%
Close Feb 26 16:00 ET
- 9.580
- 0.0000.00%
Post 20:01 ET
783.37MMarket Cap-1.21P/E (TTM)
9.970High9.400Low457.88KVolume9.780Open9.670Pre Close4.41MTurnover0.74%Turnover RatioLossP/E (Static)81.77MShares30.95852wk High3.65P/B595.98MFloat Cap8.93052wk Low--Dividend TTM62.21MShs Float63.780Historical High--Div YieldTTM5.90%Amplitude2.090Historical Low9.634Avg Price1Lot Size
About Immunome Company
Immunome, Inc. is a biopharmaceutical company, which engages in the discovery and development of antibody therapeutics products. It also focuses on oncology and infectious disease areas. The company was founded by Scott K. Dessain and Gregory P. Licholai on March 2, 2006 and is headquartered in Bothell, WA.
Company Profile
SymbolIMNM
Company NameImmunome
Listing DateOct 2, 2020
Issue Price12.00
Founded2006
CEODr. Clay B. Siegall,PhD
MarketNASDAQ
Employees55
Fiscal Year Ends12-31
Address18702 North Creek Parkway,Suite 100
CityBothell
ProvinceWashington
CountryUnited States of America
Zip Code98011
Phone1-425-939-7410
Websitehttp://www.immunome.com
Company Executives
- Name
- Position
- Salary
- Dr. Clay B. Siegall,PhD
- Chief Executive Officer, President and Chairman of the Board
- 14.87M
- Kinney Horn
- Chief Business Officer
- --
- Bob Lechleider
- Chief Medical Officer
- 2.92M
- Dr. Bruce Turner, M.D.,PhD
- Chief Strategy Officer
- --
- Sandra G. Stoneman
- Chief Legal Officer and General Counsel
- --
- Dr. Jack Higgins, PhD
- Chief Scientific Officer
- 1.84M
- Max Rosett
- Principal Accounting Officer, Executive Vice President, Operations and Interim Chief Financial Officer
- --
- Carol A. Schafer
- Director
- --
- Philip Wagenheim
- Director
- 59.23K
- Dr. Sandra M. Swain, M.D.
- Director
- --
- Isaac Barchas, J.D.
- Lead Independent Director
- 296.59K
- Jean-Jacques Bienaime
- Independent Director
- 287.93K
- James P. Boylan, M.B.A.
- Independent Director
- 294.75K